Phage combination therapy can precisely target IBD-related gut bacteria without harming helpful microbes

For the first time, scientists have designed a phage combination therapy that can precisely target and suppress gut bacteria associated with inflammatory bowel diseases (IBD). The work showcases the possibility of using phages for treating diseases associated with gut microbiota.